Your account is not claimed yet. You can sign up with ORCID to claim your account.

Thomas A Hunt (Tom Hunt)

Years Active: 2018-2022
Publications (10 Years): 2

AstraZeneca UK Ltd

University of York (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca UK Ltd Sep 1o 2014

United Kingdom

APS :: Medicinal Chemistry

Education History

University of York Oct 1o 2002 - Oct 1o 2005

United Kingdom

PHD :: Chemistry

Publications

Filip S Meger, Alexander C W Kwok, Franziska Gilch, Dominic R Willcox, Alex J Hendy, Kieran Nicholson, Andrew D Bage, Thomas Langer, Thomas A Hunt, Stephen P Thomas
B -N/ B -H Transborylation: borane-catalysed nitrile hydroboration. Beilstein journal of organic chemistry 18 (2022)
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok, Thomas A Hunt, Kurt G Pike, Joanne Wilson, Aaron Smith, Nicola Colclough, Venkatesh Pilla Reddy, Andrew Sykes, Annika Janefeldt, Peter Johnström, Katarina Varnäs, Akihiro Takano, Stephanie Ling, Jonathan Orme, Jonathan Stott, Caroline Roberts, Ian Barrett, Gemma Jones, Martine Roudier, Andrew Pierce, Jasmine Allen, Jenna Kahn, Amrita Sule, Jeremy Karlin, Anna Cronin, Melissa Chapman, Kristoffer Valerie, Ruth Illingworth, Martin Pass
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Science advances 4 (6) (2018)

Thomas A Hunt.css-eqlu8i{font-size:small;padding-left:4px;} (Tom Hunt)